These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 5800081

  • 1. [Possibilities and results of cytodiagnosis in the district health service].
    Tiser H.
    Cesk Gynekol; 1969 Jul; 34(6):337-8. PubMed ID: 5800081
    [No Abstract] [Full Text] [Related]

  • 2. [Importance of premalignant lesions in the diagnosis and prevention of cancer. Cytological advances in the diagnosis of cancer].
    Alonso P.
    Prensa Med Mex; 1970 Jul; 35(3):123-5. PubMed ID: 5518716
    [No Abstract] [Full Text] [Related]

  • 3. [Diagnosis in precancerous and early manifestations of cervix cancer in a municipal hospital].
    Hartmann G, Lau H.
    Zentralbl Gynakol; 1973 May 04; 95(18):614-7. PubMed ID: 4717304
    [No Abstract] [Full Text] [Related]

  • 4. [Cytopathological study of pre-malignant and malignant lesions of the cervix uteri].
    Pulido MA.
    Rev Colomb Obstet Ginecol; 1969 May 04; 20(5):349-64. PubMed ID: 5361321
    [No Abstract] [Full Text] [Related]

  • 5. [Possibilities of early diagnosis of endometrial cancer within the framework of activities for mass detection of cervical cancer].
    Spreafichi F, Accinelli G, Cadenelli GP.
    Quad Clin Ostet Ginecol; 1967 Nov 04; 22(11):841-67. PubMed ID: 5607085
    [No Abstract] [Full Text] [Related]

  • 6. [Results of early diagnosis of cervix carcinoma between 1962-1968].
    Kohl H.
    Zentralbl Gynakol; 1970 May 30; 92(22):691-9. PubMed ID: 5513142
    [No Abstract] [Full Text] [Related]

  • 7. [The role of cytodiagnosis in the early recognition of cancerous and precancerous conditions of the uterine cervix].
    Ruzicska G.
    Orv Hetil; 1968 May 26; 109(21):1135-9. PubMed ID: 5700740
    [No Abstract] [Full Text] [Related]

  • 8. [What factors delimit the "levels of intervention" for early diagnosis and prevention of cervix carcinoma in the consultation environment?].
    Maggi R, Gilardi L, Cristofori E.
    Ann Ostet Ginecol Med Perinat; 1982 May 26; 103(5):366-71. PubMed ID: 7158900
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Institutional trends and organizational criteria for mass detection of cancer of the uterus at the provincial level. Our experience in the province of Parma].
    Spreafichi F.
    Quad Clin Ostet Ginecol; 1967 Dec 01; 22(12):1091-116. PubMed ID: 5621700
    [No Abstract] [Full Text] [Related]

  • 13. Screening for cervical cancer.
    Wachtel E.
    Practitioner; 1973 Aug 01; 211(262):137-42. PubMed ID: 4580608
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Possibilities of increasing the reliability of pre-biopsy methods within the functional framework of the Oncology Prevention Center].
    Vorácek J, Holub Z, Tretiník P.
    Cesk Gynekol; 1988 Jul 01; 53(6):469-77. PubMed ID: 3168014
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.